A Study to Evaluate Adverse Events and How Single Ascending Doses of ABBV-141 Move Through the Body of Healthy Adult Western and Asian Participants

Study Identifier
M24-693
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Healthy Volunteer
  • Study Drug
  • ABBV-141
  • Placebo for ABBV-141
  • Phase
    Phase 1
    Sex
    Female & Male
    Age
    18 - 55 Years

    Protocol Summary

    The purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and immunogenicity after single ascending doses (SAD) of ABBV-141 in healthy adult Western and Asian participants.

    Study Locations

    Location
    Status
    Location
    Acpru /Id# 261162
    Grayslake, Illinois, United States, 60030
    Status
    Not applicable